Recombinant high-density lipoprotein nanoparticles containing gadolinium-labeled cholesterol for morphologic and functional magnetic resonance imaging of the liver

References

• CaravanPEllisonJJMcMurryTJLaufferRBGadolinium (III) chelates as MRI contrast agents: structure, dynamics, and applicationsChem Rev19999992293235211749483
   PubMed Web of Science ®Google Scholar
• GeraldesCFLaurentSClassification and basic properties of contrast agents for magnetic resonance imagingContrast Media Mol Imaging20094112319156706
   PubMed Web of Science ®Google Scholar
• SealeMKCatalanoOASainiSHahnPFSahaniDVHepatobiliary-specific MR contrast agents: role in imaging the liver and biliary treeRadiographics20092961725174819959518
   PubMed Web of Science ®Google Scholar
• LangereisSDirksenAHackengTMvan GenderenMHPMeijerEWDendrimers and magnetic resonance imagingNew J Chem200731711521160
   Web of Science ®Google Scholar
• LuoKLiuGHeBMultifunctional gadolinium-based dendritic macromolecules as liver targeting imaging probesBiomaterials201132102575258521256587
   PubMed Web of Science ®Google Scholar
• RensenPCNde VruehRLAKuiperJBijsterboschMKBiessenEALvan BerkelTJCRecombinant lipoproteins: lipoprotein-like lipid particles for drug targetingAdv Drug Deliv Rev2001472–325127611311995
   PubMed Web of Science ®Google Scholar
• ZhouPHatziieremiaSElliottMAUptake of synthetic low density lipoprotein by leukemic stem cells – a potential stem cell targeted drug delivery strategyJ Control Release2010148338038720869412
   PubMed Web of Science ®Google Scholar
• MaximovVDReukovVVBarryJNCochraneCVertegelAAProtein-nanoparticle conjugates as potential therapeutic agents for the treatment of hyperlipidemiaNanotechnology2010212626510320534889
   PubMed Web of Science ®Google Scholar
• CrichSGLanzardoSAlbertiDMagnetic resonance imaging detection of tumor cells by targeting low-density lipoprotein receptors with Gd-loaded low-density lipoprotein particlesNeoplasia20079121046105618084612
   PubMed Web of Science ®Google Scholar
• ZhangXChenBRecombinant high density lipoprotein reconstituted with apolipoprotein AI cysteine mutants as delivery vehicles for 10-hydroxycamptothecinCancer Lett20102981263320579804
   PubMed Web of Science ®Google Scholar
• FengMCaiQHuangHZhouPLiver targeting and anti-HBV activity of reconstituted HDL-acyclovir palmitate complexEur J Pharm Biopharm200868368869317890068
   PubMed Web of Science ®Google Scholar
• OdaMNHargreavesPLBecksteadJARedmondKAvan AntwerpenRRyanROReconstituted high density lipoprotein enriched with the polyene antibiotic amphotericin BJ Lipid Res200647226026716314670
   PubMed Web of Science ®Google Scholar
• FirestoneRALow-density lipoprotein as a vehicle for targeting antitumor compounds to cancer cellsBioconjug Chem1994521051138031872
   PubMed Web of Science ®Google Scholar
• van der VeldeAEReverse cholesterol transport: from classical view to new insightsWorld J Gastroenterol201016475908591521157966
   PubMed Web of Science ®Google Scholar
• FriasJCWilliamsKJFisherEAFayadZARecombinant HDL-like nanoparticles: a specific contrast agent for MRI of atherosclerotic plaquesJ Am Chem Soc200412650163161631715600321
   PubMed Web of Science ®Google Scholar
• CormodeDPChandrasekarRDelshadAComparison of synthetic high density lipoprotein (HDL) contrast agents for MR imaging of atherosclerosisBioconjug Chem200920593794319378935
   PubMed Web of Science ®Google Scholar
• CormodeDPSkajaaTvan SchooneveldMMNanocrystal core high-density lipoproteins: a multimodality contrast agent platformNano Lett20088113715372318939808
   PubMed Web of Science ®Google Scholar
• SkajaaTCormodeDPJarzynaPAThe biological properties of iron oxide core high-density lipoprotein in experimental atherosclerosisBiomaterials201132120621320926130
   PubMed Web of Science ®Google Scholar
• SriramRLagerstedtJOPetrlovaJImaging apolipoprotein AI in vivoNMR Biomed201124791692421264979
   PubMed Web of Science ®Google Scholar
• RomaPGreggREMengMSIn vivo metabolism of a mutant form of apolipoprotein A-I, apo A-I Milano, associated with familial hypoalphalipoproteinemiaJ Clin Invest1993914144514528473493
   PubMed Web of Science ®Google Scholar
• MalmendierCLDelcroixCAmeryckxJPIn vivo metabolism of human apoprotein A-I-phospholipid complexes. Comparison with human high density lipoprotein-apoprotein A-I metabolismClin Chim Acta198313132012106411388
   PubMed Web of Science ®Google Scholar
• IdeeJMPortMRaynalISchaeferMLe GreneurSCorotCClinical and biological consequences of transmetallation induced by contrast agents for magnetic resonance imaging: a reviewFundam Clin Pharmacol200620656357617109649
   PubMed Web of Science ®Google Scholar
• RyanROForteTMOdaMNOptimized bacterial expression of human apolipoprotein A-IProtein Expr Purif20032719810312509990
   PubMed Web of Science ®Google Scholar
• WaterhouseJEHarbottleRPKellerMSynthesis and application of integrin targeting lipopeptides in targeted gene deliveryChembiochem2005671212122315937988
   PubMed Web of Science ®Google Scholar
• FunkGMHuntCEEppsDEBrownPKUse of a rapid and highly sensitive fluorescamine-based procedure for the assay of plasma lipoproteinsJ Lipid Res19862777927953760715
   PubMed Web of Science ®Google Scholar
• NagarajaTNCroxenRLPandaSApplication of arsenazo III in the preparation and characterization of an albumin-linked, gadolinium-based macromolecular magnetic resonance contrast agentJ Neurosci Methods2006157223824516769125
   PubMed Web of Science ®Google Scholar
• ForteTMNordhausenRWElectron microscopy of negatively stained lipoproteinsMethods Enzymol19861284424572425222
   PubMed Web of Science ®Google Scholar
• TamatSRMooreDEAllenBJDetermination of boron in biological tissues by inductively coupled plasma atomic emission spectrometryAnal Chem19875917216121643674433
   PubMed Web of Science ®Google Scholar
• NicholsAVKraussRMMuslinerTANondenaturing polyacrylamide gradient gel electrophoresisMethods Enzymol19861284174313724517
   PubMed Web of Science ®Google Scholar
• MaximovVDReukovVVBarryJNCochraneCVertegelAAProtein-nanoparticle conjugates as potential therapeutic agents for the treatment of hyperlipidemiaNanotechnology2010212626510320534889
   PubMed Web of Science ®Google Scholar
• ForteTMNikanjamMBlakelyEABjornstadKAShuXBudingerTFSynthetic nano-low density lipoprotein as targeted drug delivery vehicle for glioblastoma multiformeInt J Pharm20073281869416959446
   PubMed Web of Science ®Google Scholar
• JiBPeacockGLuDRSynthesis of cholesterol-carborane conjugate for targeted drug deliveryBioorg Med Chem Lett200212172455245812161156
   PubMed Web of Science ®Google Scholar
• ChuACYTsangSYLoEHKFungKPLow density lipoprotein as a targeted carrier for doxorubicin in nude mice bearing human hepatoma HepG2 cellsLife Sci200170559160111811903
   PubMed Web of Science ®Google Scholar
• CallahanDEForteTMAfzalSMBoronated protoporphyrin (BOPP): localization in lysosomes of the human glioma cell line SF-767 with uptake modulated by lipoprotein levelsInt J Radiat Oncol Biol Phys199945376177110524433
   PubMed Web of Science ®Google Scholar
• VitolsSSoderberg-ReidKMasquelierMSjostromBPetersonCLow density lipoprotein for delivery of a water-insoluble alkylating agent to malignant cells. In vitro and in vivo studies of a drug-lipoprotein complexBr J Cancer19906257247292245164
   PubMed Web of Science ®Google Scholar
• LeeHKimSIShinDHepatic siRNA delivery using recombinant human apolipoprotein A-I in miceBiochem Biophys Res Commun2009378219219619017527
   PubMed Web of Science ®Google Scholar
• FengMQCaiQSShiXLHuangHZhouPGuoXRecombinant high-density lipoprotein complex as a targeting system of nosiheptide to liver cellsJ Drug Target200816650250818604663
   PubMed Web of Science ®Google Scholar
• KnowlesBBHoweCCAdenDPHuman hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigenScience198020944554974996248960
   PubMed Web of Science ®Google Scholar
• AdenDPFogelAPlotkinSDamjanovIKnowlesBBControlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell lineNature19792825739615616233137
   PubMed Web of Science ®Google Scholar
• Mersch-SundermannVKnasmullerSWuXJDarroudiFKassieFUse of a human-derived liver cell line for the detection of cytoprotective, antigenotoxic and cogenotoxic agentsToxicology20041981–332934015138059
   PubMed Web of Science ®Google Scholar
• RhaindsDBourgeoisPBourretGHuardKFalstraultLBrissetteLLocalization and regulation of SR-BI in membrane rafts of HepG2 cellsJ Cell Sci2004117Pt 153095310515226391
   PubMed Web of Science ®Google Scholar
• VantouroutPRadojkovicCLichtensteinLPonsVChampagneEMartinezLOEcto-F-ATPase: a moonlighting protein complex and an unexpected apoA-I receptorWorld J Gastroenterol201016475925593521157968
   PubMed Web of Science ®Google Scholar
• ConnollyDTKrulESHeuvelmanDGlennKCInhibition of cholesteryl ester transfer protein by apolipoproteins, lipopolysaccharides, and cholesteryl sulfateBiochim Biophys Acta1996130421451608954138
   PubMed Web of Science ®Google Scholar
• StarkDDWeisslederRElizondoGSuperparamagnetic iron oxide: clinical application as a contrast agent for MR imaging of the liverRadiology198816822973013393649
   PubMed Web of Science ®Google Scholar
• CittadinoEFerrarettoMTorresEMRI evaluation of the antitumor activity of paramagnetic liposomes loaded with prednisolone phosphateEur J Pharm Sci201245443644121896328
   PubMed Web of Science ®Google Scholar
• LuoKLiuGSheWCGadolinium-labeled peptide dendrimers with controlled structures as potential magnetic resonance imaging contrast agentsBiomaterials201132317951796021784511
   PubMed Web of Science ®Google Scholar
• KobayashiHBrechbielMWNano-sized MRI contrast agents with dendrimer coresAdv Drug Deliv Rev200557152271228616290152
   PubMed Web of Science ®Google Scholar
• ChenZJYuDXLiuCXGadolinium-conjugated PLA-PEG nanoparticles as liver targeted molecular MRI contrast agentJ Drug Target201119865766521091273
   PubMed Web of Science ®Google Scholar
• LeeNKKimSLeeJWBiliary MR imaging with Gd-EOB-DTPA and its clinical applicationsRadiographics20092961707172419959517
   PubMed Web of Science ®Google Scholar
• RyeomHKKimSHKimJYQuantitative evaluation of liver function with MRI using Gd-EOB-DTPAKorean J Radiol20045423123915637473
   PubMed Web of Science ®Google Scholar
• Schuhmann-GiamperiGLiver contrast media for magnetic resonance imaging: interrelations between pharmacokinetics and imagingInvest Radiol19932887537618376008
   PubMed Web of Science ®Google Scholar
• LeonhardtMKeiserMOswaldSHepatic uptake of the magnetic resonance imaging contrast agent Gd-EOB-DTPA: role of human organic anion transportersDrug Metab Dispos20103871024102820406852
   PubMed Web of Science ®Google Scholar
• ClementOMuhlerAVexlerVBerthezeneYBraschRCGadolinium-ethoxybenzyl-DTPA, a new liver-specific magnetic resonance contrast agent. Kinetic and enhancement patterns in normal and cholestatic ratsInvest Radiol19922786126191428739
   PubMed Web of Science ®Google Scholar
• EvenepoelPZeegersMSegaertSNephrogenic fibrosing dermopathy: a novel, disabling disorder in patients with renal failureNephrol Dial Transplant200419246947314736976
   PubMed Web of Science ®Google Scholar
• CowperSENephrogenic systemic fibrosis: an overviewJ Am Coll Radiol200851232818180005
   PubMedGoogle Scholar